LIVN

Livanova Plc

• Simply Wall St·3d ago

  LivaNova (LIVN) Faces A Fresh Test Following Its Neuromodulation Narrative

• Seeking Alpha·3d ago

  Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTech

• TipRanks·3d ago

  Flutter upgraded, AppFolio downgraded: Wall Street’s top analyst calls

• Dow Jones·3d ago

  LivaNova Initiated at Overweight by Barclays

• TipRanks·4d ago

  LivaNova initiated with an Overweight at Barclays

• Simply Wall St·09/24 17:34

  LivaNova (LIVN) Looks Mispriced Following A Pullback In A Stronger Long Term Story

• Simply Wall St·09/11 15:23

  LivaNova (LIVN) Could Be 12% Undervalued Following Recent Share Price Cooling

• The Motley Fool·09/11 01:15

  LivaNova Director Sells 1,650 Shares for $131,500

• TipRanks·09/03 02:05

  Insider Shake-Up: High-Level LivaNova Stock Sale Turns Heads

• Benzinga·09/02 16:33

  Piper Sandler Reiterates Overweight on LivaNova, Raises Price Target to $90

• TipRanks·09/02 10:45

  LivaNova price target raised to $90 from $87 at Piper Sandler

• Simply Wall St·09/01 10:30

  LivaNova (LIVN) Stock May Be Below Fair Value But Fair On Earnings

• Seeking Alpha·08/25 14:34

  LivaNova: Careful About The Valuation And Upside

• Seeking Alpha·08/24 19:03

  Artisan International Small-Mid Fund Q2 2026 Portfolio Review

• Simply Wall St·08/24 14:24

  Is LivaNova (LIVN) Fairly Valued As Growth Hopes Meet Reimbursement Risks?